ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

Physicians Group Makes No “Simple Recommendation” on Mammograms for Women Aged 40-49.

April 6, 2007

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996